Northwestern Medicine Division of MS and Neuroimmunology

Chicago, Illinois

Academic MS Center
10 Active TrialsLarge Center
13 MS centers statewide · Ranked #1 in Illinois for clinical trials · #3 in Illinois for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health System

You’ll find an academic MS and neuroimmunology center where care is shaped by specialty expertise, research, and training. You can expect a team-based approach with access to advanced therapies, brain MRI, and blood biomarker testing. You may need to plan ahead for a larger academic setting, with care spread across multiple affiliated sites.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services3/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care1/5

About Northwestern Medicine Division of MS and Neuroimmunology

This center stands out for its academic setting and its strong link to Northwestern University Feinberg School of Medicine. It also combines specialty MS care with fellowship training, subspecialty education, and active clinical research.

This Chicago center cares for people with multiple sclerosis, relapsing multiple sclerosis, neuromyelitis optica spectrum disorder, optic neuritis, transverse myelitis, and other inflammatory disorders of the brain and spinal cord. It brings together neurology, neuroimmunology, and adult neurology expertise through a large faculty team. Patients can also benefit from brain MRI, blood biomarker testing, and treatment options that include several advanced therapies. As part of Northwestern Medicine and Northwestern University Feinberg School of Medicine, the division combines specialty care with training and research.

Northwestern Medicine Division of MS and Neuroimmunology is an academic MS center in Chicago focused on multiple sclerosis and other neuroimmunology conditions. It is part of Northwestern Medicine and Northwestern University Feinberg School of Medicine. Patients are cared for by a team with deep subspecialty expertise, including faculty involved in MS and neuroimmunology education and fellowship training. The center also offers access to clinical trials and research alongside routine care.

Featured Care Team Members

Farrah Mateen, MD, PhD
Division Chief
Multiple sclerosis, neuromyelitis optica, related neuroimmunological disorders
Roumen Balabanov, MD
Multiple sclerosis, NMOSD, autoimmune neurology, immunotherapy
Bruce Cohen, MD
Adult neurology, multiple sclerosis clinical research
Edith Graham, MD
Neuroimmunologic disorders
Elena Grebenciucova, MD
Neuroimmunology and central nervous system inflammatory disorders
Shailee Shah
Neuroimmunology
Brian Popko, PhD
Myelin biology

Specialized Programs

Multiple Sclerosis Fellowship
Neuroimmunology and Multiple Sclerosis Education

Partnerships & Referral Network

  • Northwestern University Feinberg School of Medicine
  • Northwestern Medicine affiliated care sites

Services & Treatments

What They Treat
Multiple sclerosisRelapsing multiple sclerosisNeuromyelitis opticaNeuromyelitis optica spectrum disorderAnti-NMDA receptor encephalitisTransverse myelitisOptic neuritisOther inflammatory disorders of the brain and spinal cord
How They Treat It
Clinical care for multiple sclerosisClinical care for neuroimmunology conditionsClinical trialsFellowship trainingSubspecialty educationResearchUblituximab (Briumvi)OcrelizumabInebilizumabAutologous hematopoietic stem cell transplantGLP-1 agonists
Diagnostics
Brain MRIBlood biomarker testing

Research & Clinical Trials

This center is currently involved in 10 clinical trials — ranked #1 in Illinois for active trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
Ofatunumab
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
RECRUITINGPHASE1
Biospecimen CollectionNivolumab
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE4
OcrelizumabPlacebo for Ocrelizumab
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Northwestern University
RECRUITING
GLP-1Ocrelizumab (US)
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals
RECRUITINGPHASE2
rapcabtagene autoleucelrituximab
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RECRUITINGPHASE2
COYA 302Placebo
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Celgene
RECRUITINGPHASE3
OzanimodFingolimodPlacebo
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Northwestern University
RECRUITINGPHASE4
Ublituximab

Insurance & Access

Contact
Abbott Hall, 710 N Lake Shore Drive 11th Flr, Chicago, IL 60611
Insurance & Support

FAQs from Northwestern Medicine Division of MS and Neuroimmunology

The division treats multiple sclerosis, relapsing multiple sclerosis, neuromyelitis optica, neuromyelitis optica spectrum disorder, optic neuritis, transverse myelitis, anti-NMDA receptor encephalitis, and other inflammatory disorders of the brain and spinal cord.

Treatments mentioned for patients include ublituximab (Briumvi), ocrelizumab, inebilizumab, autologous hematopoietic stem cell transplant, and GLP-1 agonists. Your care team can help determine which options fit your situation.

Yes. Diagnostic capabilities include brain MRI and blood biomarker testing, which can help guide care for MS and related neuroimmunology conditions.

Yes. The division lists clinical trials and has active trial involvement. It also participates in research related to MS and inflammatory diseases.

You may see faculty with expertise in multiple sclerosis, neuromyelitis optica, autoimmune neurology, neuroimmunology, and myelin biology. The team includes Division Chief Farrah Mateen, MD, PhD, along with other specialty faculty.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Website